Most critically ill patients receiving mechanical ventilation who are fed enterally do not receive their energy requirements, due to frequent interruptions in enteral feedings.
Low-tidal-volume ventilation reduces mortality in ICU patients with acute lung injury and acute respiratory distress syndrome. But is it useful to apply this strategy to all ICU patients?
Exogenous surfactant decreased mortality, increased ventilator-free days, and reduced the duration of ventilation in children mechanically ventilated for acute respiratory failure.
Can we use pulmonary vasodilators (like sodium nitroprusside) in acute respiratory distress syndrome (ARDS) if there are no facilities to use nitric oxide?